Groundbreaking study reveals the connection between sugar, obesity and your gut health
Dietary sugar alters the gut microbiome, setting off a chain of events that leads to metabolic disease, pre-diabetes, and weight gain.
The Brighter Side of News features good news, compassionate news and inspirational news from around the world
Sign up for the Brighter Side of News newsletter
Joseph Shavit
- 6 days ago
Can obesity and stress influence your appetite? New study shows it’s all in your head
Researchers found that stress impacts the brain’s responses to food, and that both lean and obese adults react to food cues tied to rewards.
Joseph Shavit
- Nov 20
Researchers redefine obesity with discovery of two major subtypes
Scientists has identified two distinct types of obesity with physiological and molecular differences that may have lifelong consequences.
Joseph Shavit
- Nov 14
Drug developed to treat Alzheimer’s disease found to reduce obesity and improve heart function
Study found that a drug first developed to treat Alzheimer’s disease, schizophrenia and sickle cell disease reduces obesity and fatty liver.
Joseph Shavit
- Nov 9
Gene found that predisposes people to slimness, carried by 60% of Europeans
Researchers discovered that those who have a certain version of a gene involved in cell nutrition tend to accumulate less fat.
Joseph Shavit
- Nov 5
Groundbreaking obesity drug helps teens lose weight, study finds
A new drug which is approved for adults with obesity or overweight, also helps adolescents shed pounds and have healthier hearts.
Joseph Shavit
- Nov 4
Groundbreaking research reveals the connection between sugar, the gut and obesity
Dietary sugar alters the gut microbiome, setting off a chain of events that leads to metabolic disease, pre-diabetes, and weight gain.
Joseph Shavit
- Nov 3
Study identifies innovative new treatment for sleep apnea
Sleep-disordered breathing is characterized by breathing that stops and starts throughout sleep and affects up to 45% of obese Americans.
Joseph Shavit
- Nov 1
Nitric oxide gel therapy prevents obesity and Type 2 diabetes
Supplying exogenous nitric oxide at a sustained level may be an efficient way of treating the cardiometabolic syndrome, study finds.
Joseph Shavit
- Oct 22
Scientists uncover why late-night eating leads to weight gain and diabetes
Northwestern Medicine scientists have uncovered the mechanism behind why eating late at night is linked to weight gain and diabetes.
Joseph Shavit
- Oct 21
Drug discovery naturally converts ‘bad’ fat to ‘good’ fat
“Metabolism” describes the body’s chemical changes that create the necessary materials for growth and overall health.
Joseph Shavit
- Oct 21
Protein restriction can combat obesity and diabetes
Twenty-one patients with metabolic syndrome were given a calorie or protein restriction diet in a randomized clinical trial by researchers.
Joseph Shavit
- Oct 14
Viagra-like medication found to also reduce obesity and improve heart function
A drug first developed to treat Alzheimer’s disease and sickle cell disease reduces obesity, fatty liver and improves heart function.
Joseph Shavit
- Oct 14
Research discovery redefines obesity and epigenetics
Scientists has identified two types of obesity with physiological and molecular differences that may have lifelong consequences for health.
Joseph Shavit
- Oct 4
Study reveals the connection between sugar, the gut microbiome and obesity
A study found that dietary sugar alters the gut microbiome, setting off a chain of events that leads to metabolic disease and weight gain.
Joseph Shavit
- Oct 2
Revolutionary nitric oxide therapy prevents and treats obesity and diabetes
A novel therapy developed at the University of Alabama at Birmingham ameliorates obesity and Type 2 diabetes in mice fed a high-fat diet.
Joseph Shavit
- Sep 14
Drug first developed to treat Alzheimer’s disease reduces obesity and improves heart function
Drug first developed to treat Alzheimer’s disease, schizophrenia and sickle cell disease reduces obesity, and improves heart function.
Joseph Shavit
- Sep 14
Game-changing obesity drug more than halves risk of type 2 diabetes
The risk of type 2 diabetes (T2D) is more than halved by weekly injections of new obesity drug semaglutide, according to new research.
Joseph Shavit
- Sep 14
Scientists redefine obesity with discovery of two major subtypes
Scientists identified two distinct types of obesity with physiological and molecular differences that have lifelong consequences for health.
Joseph Shavit
- Sep 8
Bariatric surgery more effective than lifestyle for type 2 diabetes remission
Remission of type 2 diabetes is achieved more effectively and has longer-lasting results with bariatric surgery than through medications.